Elective Abdominal Aortic Aneurysm Clinical Trial
— ACEOfficial title:
ACE Trial :Not Worn-Out Aneurism of the Abdominal Aorta Under Renal " Surgery Versus Endoprosthesis "
Verified date | February 2009 |
Source | Assistance Publique - Hôpitaux de Paris |
Contact | n/a |
Is FDA regulated | No |
Health authority | France: Ministry of Health |
Study type | Interventional |
Abdominal aortic aneurysm (AAA) is a life threatening disease. There is a consensus to
propose surgical repair in patients with a reasonable operative risk when the AAA exceeds 5
cm in diameter.
The aim of the study is to compare the mortality and the occurrence of severe general,
vascular and local complications in two groups of patients treated by either by open surgery
or by EVAR (EndoVascular Aneurysm Repair). The main outcome criteria and the secondary
endpoint are respectively the survival without severe complications and minor morbidity.
Status | Completed |
Enrollment | 306 |
Est. completion date | February 2009 |
Est. primary completion date | February 2008 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 50 Years and older |
Eligibility |
Inclusion Criteria: - Patients aged 50 years old or more (more than 80 possible depending on physiological age) - Level 0, 1, or 2 of operative risk - Abdominal aortic aneurysm with a diameter > or equal to 50 mm or > or equal to 40 mm if rapid growing (10 mm or more in a year), or painful, or saccular aneurysms, or aneurisms of common iliac arteries with a diameter equal or superior to 30 mm; or women with a diameter equal to 45 mm; - Aortic neck superior or equal to 1.5 cm - No stenosis superior or equal to 75% of the superior mesenteric artery - Proximal neck angulation inferior to 80° - Diameter of the iliac arteries compatible with introducer sheath - Inform consent signed Exclusion Criteria: - Aneurysm involving the renal arteries or with the length of the neck less than 1.5 cm - Thrombus or major calcification in the neck - Diameter of the iliac arteries not compatible with introducer sheath - Level 3 of operative risk - History of major iodine allergy (Quincke oedema, anaphylactic shock) - Other comorbidity with life expectancy less than 6 months - Follow up impossible during the trial - Participation in another trial - Inform consent not signed |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
France | Hopital Henri Mondor | Creteil |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris |
France,
Lederle FA. Endovascular repair of abdominal aortic aneurysm--round two. N Engl J Med. 2005 Jun 9;352(23):2443-5. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Death and major adverse events | 4 years | Yes | |
Secondary | Minor adverse events (systemic vascular or non vascular complications) | 4 years | Yes |